FMBP also acts against the nucleotide-binding domain (NBD) of csGRP78 which interferes with the activation of STAT3 (signal transducer and activator of transcription 3) in CRC cells and results in the accumulation of reactive oxygen species and hence CRC cell growth inhibition [51]. Here, STAT3 is linked to colorectal carcinoma.